The Case for Universal Access to Hepatitis C DAA Treatment for Your PatientsHepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV) and spread through blood-to-blood...
Can Blood Tests Help Predict Liver Transplant Outcomes? As we conclude this year, the Pediatric and Rare Liver Diseases team is reflecting on the incredible progress made by our...
Congress debates appropriations and other end-of-year legislation. Biden administration issues more rulemakings. Agencies prepare for new leadership. Members of Congress have returned to Washington,...
The Most Common Chronic Liver Disease in the WorldGlobal Liver Institute on the Road Last month, the GLI team proudly attended AASLD's The Liver Meeting™, starting with our 10th anniversary...
Global Liver Institute’s Statement on Centers for Medicare & Medicaid Services Obesity Coverage Proposed RuleGlobal Liver Institute is thrilled to share that the Centers for Medicare &...
Healthy Holidays! Gut Friendly Tips and Liver Health Innovations Welcome to this special holiday edition of Liver Cancer News! As the festive season begins, read on to discover articles on liver...
Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients(Washington, D.C. November 12, 2024) – Global Liver Institute (GLI)...
After elections, a lame-duck Congress will need to pass appropriations bills and hopefully “clear the decks” by passing long-awaited health reforms Members of Congress will return to Washington, DC,...
Uniting for Equity in Liver Cancer Care This month at GLI, we're excited to spotlight our Liver Cancer Program Director, Sarah Manes, as she dives into topics on advocacy, prevalence rates, risks,...
Innovation Sparks New Ideas at NORD’s Breakthrough Summit Collaborative Voices across Rare Disorders Represented during the FDA Innovation Hub Global Liver Institute’s (GLI)...
Recent News
How the Hepatitis C Cure Affects Other Chronic ConditionsHepatitis C infection is a chronic infection of the liver by the hepatitis C virus (HCV) that continues to affect millions of people across the globe. Left untreated, infection with hepatitis C leads to...
New Administration, New Congress, and Their Health Priorities Just Starting to Take Shape The new U.S. Congress is at work in Washington, DC. It is unclear if the healthcare legislation that came so close to passage last December will be included in a March...
How to Stay Engaged Beyond Rare Liver Diseases Month – Pediatric and Rare Liver Diseases News #RareAware Campaign: Our Impact on Rare and Rural Healthcare In February, we took action to bridge healthcare gaps for rare liver disease patients in rural...
Latest Developments in Treatments In recent years, liver cancer has emerged as a significant global health concern, with increasing incidence rates and a pressing need for innovative treatment strategies. This newsletter highlights several articles that delve into the...
What’s New in 2025New Medicare Part D Updates for 2025 As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients. These updates include a $2,000 annual...
